.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
New book from Joanna Stern highlights personal breast cancer journey
Journalist and tech writer Joanna Stern explores how AI is changing how radiologists catch cancer earlier and more effectively for women worldwide.
What MASAI reinforces about AI in USA screening mammography
What can results from the MASAI randomised controlled trial tell us about the state of breast AI research in screening mammography in the United States?
ScreenPoint Medical Secures $16M to Lead the Next Phase of AI in Breast Cancer Care
ScreenPoint Medical announces $16 million investment from existing partners and research grants to fuel growth and build toward personalized care.
.png)
Explore the future of breast imaging at SBI Symposium 2026
ScreenPoint Medical to present at Society of Breast Imaging Symposium 2026, April 16 to April 19 in Seattle, WA.
.png)
New research examines autonomous AI reading of mammograms
New research from AITIC studies whether AI could safely reduce workload by excluding low-risk exams from radiologist reading.
.png)
ScreenPoint Medical demonstrates Transpara at ECR 2026
Join ScreenPoint Medical at the European Congress of Radiology, March 4-7, 2026 in Vienna, Austria.